Editor - Silvano Ferrini | Istituto Nazionale per la Ricerca sul | 20120
ISSN: 2576-3881

Journal of Cytokine Biology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Silvano Ferrini

Silvano Ferrini
Silvano Ferrini
Head of the Biotherapy
Istituto Nazionale per la Ricerca sul Cancro, Genova


Silvano Ferrini obtained his MD degree at the University of Genova in 1980 with a Thesis on “The isolation of an insulin-like activity from the serum”. In 1983 he obtained a Specialty degree in Endocrinology with a thesis on “T cell subsets in autoimmune thyroid disorders”. In 1983-1985 he completed his training in cellular immunology at the Ludwig Institute for Cancer Research, Lausanne, Switzerland, where he conducted studies on CTL cloning in ovarian cancer and on the characterization of NK and TCR gamma/delta-expressing T cell clones. In 1984 he obtained a Permanent position as research investigator at the Istituto Nazionale per la Ricerca sul Cancro in Genova. From 1995 he is Adjunct Professor of Molecular Immunology at the Degree Course in Biotechnology, University of Genoa, Faculty of Medicine. In 2005 he became Head of the Laboratory of Biotherapy (former Immunotherapy) at the same Institute. Dr. Ferrini is author of of about 180 papers in international Journals and has reached a “H index” of 47 (Google Scholar).

Research Interest

i) studies on the role of cytokines and their receptors in human tumors and leukemias and in immune-regulation
ii) preclinical studies of cancer combinational immunotherapy using immune-enhancing interleukins, genetically-modified tumor cells and antibodies.

Global Speakers in the subject

Global Experts in the subject


Dual Roles of IL-15 in Cancer Biology

Marina Fabbi and Silvano Ferrini
Review Article: J Cytokine Biol 2016, 1:103
DOI: 10.4172/2576-3881.1000103